The Company’s initial focus has been the development of instrumentation and reagents to perform and optimize the Edge technology for users doing analytical proteomics research and biomarker discovery.

Additionally, we have identified opportunities for our instrumentation products in the areas of clinical diagnostics, clinical trials, and pathological evaluation.

Prospect Biosystems?Edge?Systems address the market’s needs in the following areas:

• Biomarker discovery
• Low abundance protein isolation and enrichment
• Biological information on subcellular location
• Subcellular biology, cell biology and subcellular proteomics
• Drug target discovery and characterization
• Binding studies and protein-protein interactions